Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

eReferral Between Hospitals and Quitlines: An Emerging Tobacco Control Strategy.

Tindle HA, Daigh R, Reddy VK, Bailey LA, Ochs JA, Maness MH, Davis EM, Schulze AE, Powers KM, Ylioja TE, Baca HB, Mast JL, Freiberg MS; Pennsylvania eReferral Workgroup.

Am J Prev Med. 2016 Oct;51(4):522-6. doi: 10.1016/j.amepre.2016.05.024. Epub 2016 Jul 29. Review. No abstract available.

PMID:
27476383
2.

Neurotoxin-induced paralysis: a case of tick paralysis in a 2-year-old child.

Taraschenko OD, Powers KM.

Pediatr Neurol. 2014 Jun;50(6):605-7. doi: 10.1016/j.pediatrneurol.2014.01.041. Epub 2014 Jan 24.

PMID:
24679414
3.

Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe.

Hernandez FJ, Huang L, Olson ME, Powers KM, Hernandez LI, Meyerholz DK, Thedens DR, Behlke MA, Horswill AR, McNamara JO 2nd.

Nat Med. 2014 Mar;20(3):301-6. doi: 10.1038/nm.3460. Epub 2014 Feb 2.

4.

MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis.

Pacheco SA, Hsu FF, Powers KM, Purdy GE.

J Biol Chem. 2013 Aug 16;288(33):24213-22. doi: 10.1074/jbc.M113.473371. Epub 2013 Jul 8.

5.

Autophagic Killing Effects against Mycobacterium tuberculosis by Alveolar Macrophages from Young and Aged Rhesus Macaques.

Pacheco SA, Powers KM, Engelmann F, Messaoudi I, Purdy GE.

PLoS One. 2013 Jun 18;8(6):e66985. doi: 10.1371/journal.pone.0066985. Print 2013.

6.

Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.

Foss MH, Powers KM, Purdy GE.

Biochemistry. 2012 Dec 11;51(49):9922-9. doi: 10.1021/bi301426j. Epub 2012 Nov 30.

7.

Mycobacterium smegmatis RoxY is a repressor of oxyS and contributes to resistance to oxidative stress and bactericidal ubiquitin-derived peptides.

Daugherty A, Powers KM, Standley MS, Kim CS, Purdy GE.

J Bacteriol. 2011 Dec;193(24):6824-33. doi: 10.1128/JB.05492-11. Epub 2011 Oct 7.

8.

RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers.

Dobosy JR, Rose SD, Beltz KR, Rupp SM, Powers KM, Behlke MA, Walder JA.

BMC Biotechnol. 2011 Aug 10;11:80. doi: 10.1186/1472-6750-11-80.

9.

Occupational factors and risk of Parkinson's disease: A population-based case-control study.

Firestone JA, Lundin JI, Powers KM, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H.

Am J Ind Med. 2010 Mar;53(3):217-23. doi: 10.1002/ajim.20788.

10.

Dietary fats, cholesterol and iron as risk factors for Parkinson's disease.

Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H.

Parkinsonism Relat Disord. 2009 Jan;15(1):47-52. doi: 10.1016/j.parkreldis.2008.03.002. Epub 2008 Apr 18.

11.

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.

Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H.

Mov Disord. 2008 Jan;23(1):88-95.

PMID:
17987647
12.

5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study.

Kelada SN, Checkoway H, Kardia SL, Carlson CS, Costa-Mallen P, Eaton DL, Firestone J, Powers KM, Swanson PD, Franklin GM, Longstreth WT Jr, Weller TS, Afsharinejad Z, Costa LG.

Hum Mol Genet. 2006 Oct 15;15(20):3055-62. Epub 2006 Sep 8.

PMID:
16963468
13.

Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.

Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H.

Parkinsonism Relat Disord. 2006 Apr;12(3):185-9. Epub 2005 Dec 20.

PMID:
16364673
14.

No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.

Okada S, Farin FM, Stapleton P, Viernes H, Quigley SD, Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H.

Neurosci Lett. 2005 Mar 3;375(3):178-80. Epub 2004 Dec 10.

PMID:
15694256
15.

Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes.

Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H.

Neurology. 2003 Jun 10;60(11):1761-6.

PMID:
12796527
16.
17.
18.

Cerebral blood flow determinations using fluorescent microspheres: variations on the sedimentation method validated.

Powers KM, Schimmel C, Glenny RW, Bernards CM.

J Neurosci Methods. 1999 Mar 1;87(2):159-65.

PMID:
11230812
19.

Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study.

Scism JL, Powers KM, Artru AA, Lewis L, Shen DD.

Brain Res. 2000 Nov 24;884(1--2):77-86.

PMID:
11082489
21.

Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel.

Powers KM, Wilkowski MJ, Helmandollar AW, Koenig KG, Bolton WK.

Am J Kidney Dis. 2000 Feb;35(2):266-74.

PMID:
10676726
22.
23.

Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.

Scism JL, Powers KM, Artru AA, Chambers AC, Lewis L, Adkison KK, Kalhorn TF, Shen DD.

Drug Metab Dispos. 1997 Dec;25(12):1337-46.

PMID:
9394022
24.

Effect of chronic cocaine exposure on the hemodynamic response to vasopressors in sheep.

Bernards CM, Cullen BF, Powers KM.

J Trauma. 1997 Oct;43(4):680-6.

PMID:
9356067
25.

Furosemide decreases cerebrospinal fluid formation during desflurane anesthesia in rabbits.

Artru AA, Powers KM.

J Neurosurg Anesthesiol. 1997 Apr;9(2):166-74.

PMID:
9100189
26.

Intravenous lidocaine decreases but cocaine does not alter the rate of cerebrospinal fluid formation in anesthetized rabbits.

Artru AA, Bernards CM, Mautz DS, Powers KM.

J Neurosurg Anesthesiol. 1997 Jan;9(1):31-43.

PMID:
9016439
27.
28.

Effect of para-aminohippurate on the efflux of valproic acid from the central nervous system of the rabbit.

Adkison KD, Powers KM, Artru AA, Shen DD.

Epilepsy Res. 1996 Mar;23(2):95-104.

PMID:
8964279
29.

Role of choroid plexus epithelium in the removal of valproic acid from the central nervous system.

Adkison KD, Artru AA, Powers KM, Nochlin D, Shen DD.

Epilepsy Res. 1995 Mar;20(3):185-92.

PMID:
7796790
30.

Clearance of valproic acid from cerebrospinal fluid in anesthetized rabbit.

Artru AA, Adkinson KD, Powers KM, Shen DD.

J Neurosurg Anesthesiol. 1994 Jul;6(3):193-200.

PMID:
7521700

Supplemental Content

Loading ...
Support Center